January 15, 2014
Tegra Medical Appoints New President and Chief Executive Officer
FRANKLIN, MA–Tegra Medical is very pleased to announce the appointment of Mr. J. Mark King as its new President and Chief Executive Officer. Mark was promoted from his current role of Chief Operating Officer, in which he has overseen the company’s four facilities in Massachusetts, Mississippi, and Costa Rica. Mr. King joined Tegra Medical in 2012 with 20+ years of broad-based operations, sales, engineering and manufacturing experience in medical device businesses, both in branded product lines and in contract manufacturing. Prior to joining Tegra, Mark was President and CEO of Clinical Innovations, a market leader in women’s health medical devices. During his career, he has held leadership positions with several other related companies, including Baxter Healthcare, Cardinal Health and Johnson and Johnson. Mark is a Six Sigma Green Belt.
“I am eager to continue the operational progress we have achieved at Tegra so that we can serve our customers well,” said King. “Tegra Medical remains committed to developing and manufacturing products for our top-tier medical devices partners that improve healthcare outcomes for clinicians and their patients worldwide. Our employees strive to exceed our customers’ expectations each and every day. They take great pride and ownership of our business, with which I am proud to be associated.”
“We are very excited to promote Mark to CEO of Tegra Medical. As the Chief Operating Officer of Tegra, Mark has demonstrated tremendous leadership, commitment and execution. I am confident that Mark will provide complete continuity for our customers and employees and that he will continue to lead Tegra’s efforts to deliver operational excellence for our customers,” said David Belluck, Chairman of the Board of Tegra Medical and General Partner of Riverside Partners.